Day traders' after-market lounge February 9, page-58

My dark horse

BIT - Biotron is an unloved bio that has small molecule compounds to fight viruses, and has completed phase 2 in developing a HIV antiviral. You can see the Oct 2018 spike to 45c when it achieved that (labelled 1).

More recently, they are working on SARS-CoV-2, and the February 2020 spike - labelled 2 - got the ball rolling again. However, one year has past and second round of COVID results were due before end of 2020.

I'm interpreting this lateness as good news for reasons I won't explain here.

Biotron are not new to to SARS viruses. They did a lot of research back at the first outbreak in 2003, and filed a relevant patent in 2019, just prior to SARS2 appearing.

Thursdays are their traditional news days. Chart is whispering that it will be this week. Imagine a potential COVID antiviral going into phase 1 trials. I can't state strongly enough how important this would be.



For those interested in a small paper I wrote on why I believe Biotron are in with a fighting chance, read here: https://hotcopper.com.au/posts/43808854/single